Abstract
Although the oligomeric states of G-protein-coupled receptors (GPCRs) and interactions with cognate G proteins are central to their signal transduction capabilities, they remain poorly defined. In this study, we used small-angle neutron scattering (SANS) and a neutron contrast matching approach to elucidate the oligomeric states of the archetypal GPCR, rhodopsin, and its interaction with the G protein transducin (Gt). At a rhodopsin/lipid molar ratio of 1/360, we found that dark-adapted rhodopsin exists as a monomer, a finding consistent with its high functional activity measured upon photoactivation by spectrophotometry and the rate of catalyzed [35S]-GTP-γ-S exchange. Following light activation, we observed that rhodopsin forms a stable 1:1 stoichiometric complex with Gt, the structure of which is consistent with recent cryo-EM data. In contrast, activated rhodopsin in the absence of Gt showed a propensity to form higher order oligomers. This research underscores the concentration-dependent nature of rhodopsin oligomerization and establishes SANS and the ability to produce appropriately contrast-matched samples, as a robust strategy for characterizing integral membrane protein interactions under biologically relevant conditions.
Keywords: Small Angle Neutron Scattering, G protein-coupled membrane receptor, G protein, rhodopsin, transducin, lipid bilayers
Graphical Abstract

1. Introduction
G protein-coupled receptors (GPCRs) are cell surface receptors characterized by a seven alpha-helical transmembrane structure that interact with members of the heterotrimeric G protein family upon ligand binding. GPCRs are essential for cellular communication, transducing external signals from hormones, neurotransmitters, ions, photons, odorants, and other stimuli into intracellular signaling responses. Recent advances, including the availability of over 450 unique structures from X-ray crystallography and cryo-Electron Microscopy studies (cryo-EM) [1], have revealed GPCRs as being highly dynamic, allosteric proteins with multiple and complex conformational states. These distinct three-dimensional structures, which are influenced by ligands and effectors, are responsible for receptor activation, signaling pathways and ultimately, important physiological responses [2, 3]. Oligomerization has emerged as a crucial mechanism regulating GPCR biosynthesis, ligand binding, G protein coupling, and downstream signaling [1] and reference therein. Despite their importance, determining GPCR oligomeric states within a functional membrane environment remains a significant challenge.
Here, we used small angle neutron scattering (SANS) to measure GPCR oligomerization and to follow the activation of its associated G protein. We chose rhodopsin – the GPCR responsible for low-light photoreception in vertebrates – as a model GPCR, because it is by far the best understood GPCR both structurally and mechanistically. Rhodopsin consists of the apoprotein opsin and its light absorbing 11-cis retinal chromophore that is covalently bound by a protonated Schiff base to Lys 296, which is located in the transmembrane helix VII. In the dark, 11-cis retinal behaves as an inverse agonist that keeps rhodopsin in its least active state, ensuring negligible basal activity of the receptor. Photon absorption triggers the in situ isomerization of 11-cis retinal into its all-trans form, and following a cascade of intermediate conformations, the formation of a G protein dependent equilibrium between meta-rhodopsin I (MI) and several distinct meta-rhodopsin II states (MII). MI formation, which takes place within microseconds, involves localized changes near the retinal binding pocket, maintaining a structure similar to dark-adapted rhodopsin; importantly, MI cannot bind G protein. In contrast, MII formation takes place on a timescale of milliseconds and is characterized by larger conformational changes taking place outside the protein’s photochemical core. These structural changes alter the cytoplasmic receptor surface to allow two orders of magnitude higher rates of catalytic nucleotide exchange after binding of the G protein transducin (Gt), triggering a biochemical amplification cascade, which in vivo, ultimately results in the signaling of second order neurons and a visual signal. In rod outer segments, the reaction is terminated by rhodopsin phosphorylation by rhodopsin kinases which allow arrestin binding and prevent further activation of Gt e.g. Gulati et al. [4] and references therein.
Since protein oligomerization is thought to be concentration dependent, rhodopsin was reconstituted into phosphatidylcholine (PC) bilayers over a wide range of concentrations, from physiologically relevant to very dilute. The MII/MI ratio was measured by spectrophotometry to establish a concentration threshold at which the MII/MI equilibrium was independent of rhodopsin concentration, suggesting a homogenous protein structure. SANS experiments were conducted on dark adapted rhodopsin as well as opsin in a lipid bilayer. Interaction between photoactivated rhodopsin and Gt was quantitatively measured by the rate of [35S]-GTP-γ-S binding and SANS experimentation. Our findings indicate that dark-adapted rhodopsin, at a rhodopsin/lipid molar ratio of 1/360, exists as a monomer and has high functional activity. When exposed to light, rhodopsin forms a stable 1:1 complex with Gt, in agreement with recent cryo-EM structural data. In contrast, activated rhodopsin in the absence of Gt formed higher-order oligomers. Our study highlights the concentration-dependent nature of rhodopsin oligomerization and establishes SANS and contrast matching methodology as a powerful experimental approach for studying the interactions between integral and peripheral membrane proteins under biologically relevant conditions.
2. Material and methods
Sample Preparation. 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC-d82) (Fig. SI1A) and 1-stearoyl-2-oleolyl-sn-glycero-3-phosphocholine (SOPC) were purchased from Avanti Polar Lipids Inc. (Alabaster, AL) and used as supplied. Rhodopsin was purified from bovine retinas using procedures adapted from the method of Khun by the Litman laboratory [5]. Rhodopsin fractions purified from bovine retinas were solubilized in 3 wt.% octylglucoside (OG), resulting in a UV-vis absorption ratio at 280 nm/500 nm of 1.8 or lower were used. Gt was extracted from a highly purified fraction of bovine retinae rod outer segments (ROS). Gt extracted from ROS was further purified using a 50 mL DEAE Sephacel (Sigma-Aldrich) column and eluted with a solution of 20 mM Tris, 0.5 mg MgCl2, 30 μM GTP, 1 mM DTT, 500 mM NaCl, pH 7.5 with added protease inhibitor. The DEAE elution solution was exchanged to 10 mM MOPS, pH 7.5 using an Amicon concentrator (MW cutoff 30 kDa) and the protein concentrated to up to 12 mg/mL. For long-term storage, Gt was lyophilized and redissolved in H2O to its initial concentration, as needed.
For the reconstitution of rhodopsin into membranes and for MI-MII equilibrium measurements, the rhodopsin solution in OG was mixed with a micellar lipid/OG solution to adjust the protein/lipid ratio. After equilibration, the protein/lipid/OG micellar solution was added dropwise at a rate of 400 μL/min to deoxygenated Piperazine-N,N′-bis(2-ethanesulfonic acid (PIPES) buffer (10 mM PIPES, 100 mM NaCl, 50 μM diethylenetriaminepentaacetic acid (DTPA), pH 7.0) under rapid stirring, resulting in the formation of proteoliposomes. Protein content in the final sample was determined spectrophotometrically by measuring the absorbance of dark-adapted rhodopsin at 500 nm before and after photobleaching, using an extinction coefficient of 40,600 M−1·cm−1 at its absorbance maximum to calculate concentration. Lipid concentration was measured by NMR.
To determine the MII/MI ratio after photoactivation, four absorption spectra were collected sequentially using an Agilent 8453 diode array spectrophotometer. The acquired spectra were as follows: (i) after the sample was equilibrated in the dark at 37°C; (ii) 3 s after 15–20% of the sample was bleached by a 520-nm flash; (iii) 10 min after addition of 30 mM hydroxylamine to convert bleached rhodopsin to opsin and retinal oxime; and (iv) after complete bleaching of the sample. Individual MI and MII spectra were deconvolved from spectra of their equilibrium mixture using extinction coefficients at their absorbance maxima of 44,000 and 38,000 cm−1, for MI and MII, respectively.
Gt activation assays were based on a method outlined in [6]. The catalyzed dissociation of Gt into unoccupied Gα and Gβγ by photoactivated rhodopsin was measured using the [35S]-GTP-γ-S binding. Briefly, the binding of [35S]-GTP-γ-S to Gα was carried out in a solution containing 0.25 μM of Gt⦁GDP in 20 mM MOPS (pH 7.5), 3 mM MgSO4, 1mM Ethylenediaminetetraacetic acid (EDTA), 1 mM DTT, 3 mg/mL Bovine Serum Albumine (BSA), 100 mM NaCl, 0.1 % Na-cholate, and [35S]-GTP-γ-S at a radiospecific activity 5000 cpm/pmol. For experiments measuring the time dependence of rhodopsin catalyzed GTP-γ-S binding to Gt, sonicated disks (or reconstituted vesicles) containing various concentrations of rhodopsin were added and kept in the dark for 30 minutes at 22° C prior to photoactivation for equilibration (t1/2 3 min). Assays were initiated by a flash of light (520 nm, 1cm) and then placed in the dark. Under these conditions, it was determined that the concentration of activated protein was independent of membrane concentration. Assays were terminated at different times (between 5 and 1800 s) by diluting 10 μl aliquots of the reaction directly into 2 ml of an ice-cold solution containing 10 mM Tris-HC1 (pH 8), 100 mM NaC1, and 25 mM MgC12 (solution D). Samples were collected and held on ice prior to rapid filtration using 0.45-pm nitrocellulose membranes (25 mm, Millipore type HA) under a vacuum of 600 mm Hg. Unbound [35S]-GTP-γ-S was removed by sequential washing of the membranes seven times with 2-ml samples of ice-cold solution D. Membranes were then dried, and the radioactivity associated with membranes was measured after addition of 10 ml of a toluene and 0.5 % 2,5-diphenyloxazole mixture. Nonspecific binding was determined by the absence of Gtα in the reaction mixture.
MII stability measurements were performed using vesicles containing dark-adapted rhodopsin (P/L = 1/4000) that were preincubated with or without Gt for 30 min (reaction solution 1). The assay was initiated by a flash of light (520-nm, 1 cm), which resulted in 65 ± 1% of the rhodopsin being activated (rho*), in agreement with the quantum yield of retinal [7, 8]. At selected time interval ranging between 0.08 and 120 min, 10 uL of the vesicle mixture (0.015 uM total rhodopsin) was added to 30 uL of a solution containing Gt at 0.225 μM in 20 mM 3-(N-morpholino) propanesulfonic acid (MOPS) (pH 7.5), 3 mM MgSO4, 1mM EDTA, 1 mM DTT, 3 mg/mL BSA, 100 mM NaCl, 0.1 % Na-cholate, and [35S]-GTP-γ-S at a radiospecific activity 5000 cpm/pmol (reaction solution 2). Reaction solution 2 was equilibrated at 22° C in a water bath 2 min prior to use. After 1 minute, this secondary reaction was terminated (as described above) and the initial rate of Gt activation as a function of the time after rhodopsin activation was determined. The amount of Gt carried from reaction solution 1 to reaction solution 2 was negligible – between 0.8 and 6% of the total Gt concentration.
SANS. Experiments were conducted at the Bio-SANS beamline (CG-3) [9], located at the Oak Ridge National Laboratory High Flux Isotope Reactor with a neutron wavelength, λ, of 6 Å, having a wavelength distribution, Δλ/λ, of 0.132. SANS data were collected at ambient temperature and acquired over the angular range of 0.003 < q < 1 Å-1. The magnitude of scattering vector q is defined as q = 4π sin (θ) / λ where θ is the scattering angle.
Sample preparation was carried out in a darkroom. Proteoliposomes were concentrated to a rhodopsin content of ~1 mg/mL using a spin concentrator (Amicon, 100 kDa cutoff, Millipore). The proteoliposome dispersion (1.5 mL) was then dialyzed against 1 L of MOPS buffered solution (Slide-A-Lyzer membrane, 10 kDa cutoff; Pierce, Rockford, IL). The solution was exchanged three times over a 16–24 h period. The proteoliposomes were then dialyzed in 0.1–0.5 mL cassettes (Slide-A-Lyzer, 10 kDa cutoff, Pierce, Rockford, IL) against 100 mL solution of the same composition dissolved with 99.9% D2O. Samples containing rhodopsin in POPC-d82 were extruded ten times prior to SANS experiments through a 0.1 μm pore size polycarbonate filter (Whatman). Samples were loaded into 280 μL quartz absorption cells (Hellma) with a 1 mm path length. For dark adapted rhodopsin experiments, cells were packed into light-tight pouches made of aluminum foil that were cleaned with acetone before use.
Data reduction was carried out using the Mantid software package [10], while determination of the radius of gyration, protein molecular weight and form factor were conducted using the SasView software suite. Background subtraction was performed using the BioXTAS RAW 2 suite [11] and calculation of SANS intensity from PDB files was carried out with the CRYSON program [12]. The PDB files used were PDB ID: 6OY9 (rhodopsin-Gt complex) and a snapshot extracted from a μsec all-atom simulation of rhodopsin in the MI state performed using 1-stearoyl-2-docohexaenoyl-sn-glycero-3-phosphatidylethanolamine (18:0–22:6 PE) lipids (files provided on demand). POPC-d82 liposomes in 99.9% D2O were used as the background sample in our proteoliposome experiments. We should note that perdeuterated lipids in 99.9% D2O and the deuterated proteoliposomes in 99.9% D2O are not perfectly equivalent. Specifically, the average neutron scattering length density of the proteoliposomes is closer to that of D2O, resulting in an over subtraction of scattering signal at low q ranges in the processed scattering data (Figure SI1B, C and SI2) limiting the useful q-range at the low end to approximately 0.01 Å−1.
3. Results
3.1. MI-MII equilibrium depends on rhodopsin membrane density.
Previous studies by Soubias et al. [13–15] and others [16] have observed a link between rhodopsin density, membrane lipid composition and fraction of MII in reconstituted membranes. Because those studies were limited to protein/lipid ratios (P/L) of between 1/1000 and 1/70 - the latter corresponding to the physiological ratio observed in rod outer segment (ROS) disks - we felt it necessary to extend those studies to lower protein densities. Dark adapted rhodopsin was reconstituted into PC bilayers at P/L ratios ranging from 1/6,000 – 1/70. The fraction of MII after photoactivation by a flash of light and the catalytic power (Vmax/Km) of Gt exchange were measured by spectrophotometry and [35S]-GTP-γ-S exchange rate, respectively (Fig. 1A, B). While the amount of MII was high and steady, ranging between 1/6,000 and 1/300, there was a continuous decrease in MII content, from 1/300 – 1/70 (Fig. 1A). Similarly, the density of rhodopsin in the vesicles profoundly influenced its catalytic power (Fig. 1B), which notably decreased as the protein/lipid ratio in the reconstituted membranes approached the physiological value observed in ROS disks membranes. This was most likely due to emerging interactions between rhodopsin either through direct protein-protein interactions or - interactions mediated by the superposition of layers of protein-associated lipids [14, 15]. Below 1/300, the fraction of MII and Gt catalytic power exchange were found to be independent of P/L. We therefore surmised that the oligomeric rhodopsin state at P/L less than 1/300 was homogeneous. As a result, all subsequent SANS experiments were conducted at a rhodopsin/PC molar ratio of 1/360 in order to achieve both a sufficiently high protein concentration and rhodopsin homogeneity.
Fig. 1. Rhodopsin concentration affects MII formation and Gt activation.
(A) Meta-rhodopsin II fraction as a function of lipid/rhodopsin ratio in 18:0–18:1-PC (SOPC) bilayers measured by UV-Vis spectroscopy at 37 °C and pH 7.4. (B) Catalytic power of Gt activation by rhodopsin as a function of lipid/rhodopsin ratio in SOPC bilayers. Vm/Km is expressed as the fraction of the maximum. To simplify data analysis, a fixed concentration of Gt > Km was used for all experiments ([Rho]=15 nM, [Gt]=250 nM).
3.2. Rhodopsin oligomeric state by SANS.
The observed intensity from a SANS experiment is sensitive to the square of the difference in NSLD of a protein and that of its surroundings. In the case of a membrane protein, the protein is surrounded by both the membrane and solvent. In order to observe scattering from just the protein, isotopic substitution of deuterium for natural abundance hydrogen may be used to tune the NSLD of the lipid membrane to match that of the solvent and enhance the difference from the protiated protein of interest. This minimizes the contribution of scattering from the liposomal particle and enhances scattering signal from the protein. The overall proton content of the sample is also reduced to minimize the large incoherent neutron scattering that contributes to the signal background and obscures the coherent scattering signal at higher angles of diffraction. This angle is expressed here as the scattering wave vector, q.
Optimal SANS experimental conditions are when a protiated protein is embedded into a perdeuterated lipid matrix, in ~ 100 % deuterated solution (see Fig. 2A, B). Fig. 3A shows a SANS profile (0.01 Å−1 < q < 0.3 Å−1) for dark adapted rhodopsin in a POPC-d82 membrane after subtraction of the residual SANS intensity due to an equivalent POPC-d82 liposome in the same D2O solution (Fig. SI1B, C). Guinier analysis of the neutron scattering signal determined a protein radius of gyration (Rg) of 21.0 ± 0.3 Å, supporting a monomeric state of rhodopsin. This value is in close agreement with the Rg calculated from the X-ray structure of dark-adapted rhodopsin (PDB ID: 1F88, 21.72 Å) and falls within 10% of the Rg obtained from snapshots extracted from an all-atom molecular dynamics (MD) simulation of rhodopsin embedded in a lipid bilayer [17] (22.2 ± 0.25 Å). The scattering data reveal no detectable structure factor arising from protein-protein interactions, reinforcing the conclusion that rhodopsin remains monomeric within the bilayer at this concentration. Further computational analysis corroborates this finding, with CRYSON-predicted SANS intensity from the PDB structure closely mirroring the experimental SANS intensity. Moreover, form-factor fitting of the SANS data provides the radial distribution function, g(r), of scattering centers. As depicted in Fig. 3B, the g(r) profiles calculated from SANS data and MD simulation snapshots align almost perfectly. Finally, modeling the rhodopsin SANS data as an elliptical cylinder (Fig. 3C, left panel) yields dimensions consistent with a monomeric form of rhodopsin.
Fig. 2. Contrast matching to highlight membrane proteins in a SANS experiment.
(A) Calculated neutron scattering length densities (NSLD) of water, lipid bilayer (volume average of headgroup- and acyl chain layers; Lipid Avg), and protein (MW 40 kDa) at a protein/lipid molar ratio of 1/500 as a function of H2O/D2O ratio. The NSLD of the protein and lipid bilayer changes with increasing D2O due the exchangeable hydrogens on the protein, as well as percent D2O. (B) NSLDs for lipid and protein as a function of percent D2O. The lipid and protein become “invisible” to neutrons at 8% and 42% D2O, respectively. Fully deuterated lipids become almost invisible at 100% D20.
Fig. 3. Rhodopsin oligomeric state determined by SANS.
(A) Scattered intensity as a function of scattering wavefactor, q, for dark adapted rhodopsin in perdeuterated 16:0–18:1 PC (POPC-d82) bilayers at 295 K. (B). Experimental and molecular dynamics simulation radial distribution functions (g(r)) for dark adapted rhodopsin in PC/PE bilayers. (C) Superimposition of I (q) data for dark adapted rhodopsin (grey square) and opsin (blue square). SANS data for rhodopsin and opsin were fitted to an elliptical cylinder.
When dark adapted samples were exposed to intense white light for one minute (entirely photobleaching the rhodopsin), the spectra changed noticeably (Fig. 3C, left panel). Analysis of the SANS data indicated the formation of higher-order oligomers of opsin under those conditions (Fig. 3C). This is evident from an increase in Rg extracted from a Guinier analysis to 38.2 +/− 0.5 Å for the opsin sample. Further analysis using an elliptical cylinder model shows a small decrease in the cylinder thickness and a significant increase in both the overall volume of the object and the aspect ratio of the cylinder. The volume is compatible with a row of 4 to 5 opsin molecules (Fig. 3, right panel).
In summary, SANS experiments showed that rhodopsin at low protein density in membranes exists as a monomer before activation and as higher order oligomers after photoactivation as it decays to opsin.
3.3. Rhodopsin-Transducin interaction by SANS.
We constructed a test to probe the stoichiometry for the activated rhodopsin-Gt complex. Key characteristics of the complex were established by Kuhn, Chabre and Hofmann in the 1980s and 1990s using isolated rod segment disk membranes [18–20]. Those pioneering studies showed that: (i) Gt binds preferentially to the MII photo intermediate and shifts the MI-MII equilibrium towards MII; (ii) binding of Gt to MII stabilizes a guanine nucleotide free state in the Gt α subunit; and (iii) binding of GTP dissociates this complex. In our test, we took advantage of the stable interaction formed between MII and Gt, which was also used to determine the structure of the rhodopsin-G protein complex using cryo-EM [21, 22].
Prior to photobleaching by a 520 nm flash of light, vesicles containing dark-adapted rhodopsin (P/L = 1/4000) were preincubated with or without Gt for 30 min. Photobleaching resulted in 65 ± 1% of rhodopsin being activated (rho*), consistent with the retinal quantum yield [23]. The decay of the MII photo intermediate was followed by measuring the initial rate of Gt activation as a function of the time after rhodopsin activation (Fig. 4A and material and methods for details). Fig. 4A shows the time dependence of the initial rate of Gt activation measured when vesicles were preincubated in the absence of Gt, in the presence of an excess of Gt and at a sub stoichiometric concentration of Gt. Without Gt, MII decayed rapidly with a half time t1/2 = 3 min. In contrast, when rhodopsin was activated in excess Gt, the decay of the MII photo intermediate was much slower (t1/2 ~ 180 min). This shows that the MII-Gt nucleotide-free complex is stable, a result that is consistent with previous observations. Note that these results were obtained in the absence of apyrase, which explains the small, but observable decay of MII over time due to potential trace amounts of nucleotide binding. Interestingly, when rhodopsin was activated in the presence of a sub stoichiometric Gt concentration, we observed two populations having different decay rates. For instance, at a ratio rho*/Gt = 0.25, half of the active rhodopsin decayed quickly with a t1/2 similar to the t1/2 decay of rhodopsin without Gt, while the other half decayed with a t1/2 corresponding to that of rhodopsin stabilized by Gt. Experiments done at rho*/Gt = 0.5 showed that the Gt concentration leading to full stabilization of the active rhodopsin is ~ ½ of the total activated rhodopsin. Assuming random rhodopsin orientation in the vesicles, these results indicate that each rhodopsin molecule binds a single Gt molecule, forming a 1:1 complex with our experimental conditions.
Fig 4. Rhodopsin- Gt complex determined by SANS.
(A) Stoichiometry of the MII-Gt complex. (top) Schematic describing the experimental set up. Equilibration step: 60 nM of rhodopsin was reconstituted in lipid vesicles (Rho: 18:0–18:1 PC = 1:4000) and Gt. Different rhodopsin to Gt ratios were premixed prior to rhodopsin being activated (30 min, Temp. 22◦C). Flash step: After loading into an automatic pipette dispenser, rhodopsin was photoactivated by a flash of light (520 nm, 1 cm). Initial rate Sampling: 10 ul of the sample was pipetted into 30 uL of Gt ( 225 nM, Buffer ), resulting in a final rhodopsin concentration of 15 nM. The fraction of rhodopsin-catalyzed [35S]-GTPγS binding to Gt was measured at 1 min. (bottom) Decay rates of MII in the absence of Gt (red circle), in the presence of excess Gt (blue square), and a Gt at a MII-Gt ratio of 4 (orange triangle) or 2 (green square). (B) Scattered intensity as a function of q for rhodopsin in a complex with Gt in perdeuterated 16:0–18:1 PC (POPC-d82) bilayers at 295 K (grey square). The data were fitted (red line) using a linear combination of back-calculated SANS curves from rhodopsin (blue) and the rhodopsin-Gt complex (green, PDB ID: 6OY9).
Fig. 4B shows a SANS profile (0.01 Å−1 < q < 0.3 Å−1) for rhodopsin photoactivated in the presence of Gt after subtraction of the residual SANS intensity due to the liposome particles and buffer (Fig. SI1). We used a sub stoichiometric amount of Gt (rho*:Gt 2:0.8) to optimize complex formation while reducing the amount of unbound transducin in the sample, considering the random orientation of insertion for rhodopsin in the membrane. This should result in a 1:1 ratio of monomeric rho* oriented with its C-terminal side to the interior of the proteoliposome and the rho*:Gt . We generated SANS predictions of the rho*:Gt complex using the CRYSON program and the published cryo-EM structure of rho*:Gt (PDB: 6OY9). Using this in combination with the monomeric calculated structure for monomeric rhodopsin allowed us to examine the SANS data in terms of a linear combination of these two contributions to the scattering. The relative intensity of each contribution is proportional to the product of the number of that type of molecule, the square of the volume of that individual scatterer, and the square of the NSLD contrast. Using the computed scattered intensity and molecular volumes provided by the CRYSON for these two structures, we constructed a combined scattering curve. The relative intensity of the two contributions was allowed to vary and was found to replicate the data closely when scaled at a 66.4 to 33.6 stoichiometry of rho* to rho*:Gt. This would be associated with a contribution from 33.6% of the number of rho*:Gt complexes, in good agreement with the expected 60:40 ratio.
4. Discussion
Neutron-based experiments have proven well-suited for the study of membranes and of membrane associated proteins [24]. For example, SANS has provided new insights into the conformational changes adopted by a range of large membrane protein systems [25]. However, smaller membrane proteins, such as rhodopsin, require a different “SANS approach” than that used for the study of larger proteins, because any amount of residual scattering from the lipids can overwhelm the signal from smaller proteins [26]. We used SANS in combination with NSLD contrast matching of the lipid matrix to probe rhodopsin oligomeric states and complexes with its G protein transducin. To increase the SANS signal from a membrane protein, the difference between the protein and lipid NSLDs needs to be maximized. Furthermore, the NSLD of the lipid matrix needs to be matched to the NSLD of the buffer, making only the protein “visible” to neutrons. Since protium is a large incoherent neutron scatterer and adds disproportionately to the background signal, especially at higher scattering angles, the sample’s proton content was also minimized. We conducted experiments on protiated protein embedded into a perdeuterated lipid matrix. The sample was hydrated using 99 % deuterated buffer.
This strategy is similar to the one developed by the Arleth group who pioneered a stealth nanodiscs strategy for small-angle neutron scattering (SANS) of protiated membrane proteins, leveraging selective deuteration to render the lipid carrier system invisible while preserving the neutron contrast of the embedded protein, enabling precise structural analysis [27–30]. Here, however, the use of lipid vesicles allows us to extend the investigation to longer-range protein-protein interactions.
Our SANS experiments revealed that rhodopsin exists predominantly as a monomer within POPC membranes prior to photoactivation, at a P/L ratio lower than 1/360. This is consistent with our prior NMR studies showing monomeric rhodopsin down to a P/L of ~1/250 and oligomerized rhodopsin at lower P/L when placed in almost perfectly hydrophobically matched membranes, such as POPC. The observation that dark adapted rhodopsin is monomeric under these experimental conditions is of functional significance. Measurements of activation rates of the native G protein transducin after photoactivation yielded the highest rates when dark-adapted rhodopsin was monomeric. The data suggest that monomeric MII is activating G protein with high efficiency, consistent with results obtained for rhodopsin embedded into lipid nanodiscs [31, 32] and in detergents [33]. Given that both MII formation and catalytic activity decline as the protein/lipid ratio approaches that of ROS membranes, this suggests that densely packed rhodopsin in ROS disks may attenuate visual transduction by limiting the population of rhodopsin in the active MII conformation and hindering lateral diffusion of transducin.
The strong agreement between our experimentally obtained SANS data and the calculated SANS profile from the cryo-EM-determined rhodopsin-Gt complex highlights the robustness of our SANS methodology. While SANS does not provide molecular details on the interaction between the two proteins, the agreement between the experimental and calculated SANS profiles not only validates the cryo-EM structure but also reinforces the utility of SANS in probing macromolecular interactions in physiologically relevant lipid environments. However, it is important to note that the non-vectorial insertion of rhodopsin which results in a random orientation further complicated our analysis, suggesting that stealth nanoscale lipid domains (nanodiscs), such as the one developed by the Arleth group [30] could offer a more effective strategy in the future for applying SANS to protein complexes that involve both membrane and cytoplasmic components. In this context, the development of larger stealth nanodiscs would represent a significant advancement, enabling the structural interrogation of membrane-associated protein complexes with molecular weights exceeding 100 kDa using SANS.
Finally, our SANS data clearly shows a shift in rhodopsin’s oligomeric state upon photoactivation and its subsequent decay to opsin, leading to the formation of higher order oligomers. An obvious question is what is triggering this monomeric to oligomeric state transition? Besides its affinity to interact with specific sites on rhodopsin [34, 35], the lipid bilayer in which the protein resides appears to play an important role [36, 37]. For example, MD simulations [38] and experiments by Brown et al. [16, 39] and our group [40], strongly suggest that elastic deformation of the lipid bilayer surrounding rhodopsin not only influences its structure, but also its states of oligomerization. The increased tendency of opsin to oligomerize is likely attributable to the interplay between its inherently more open and flexible conformation and the surrounded lipid matrix. Opsin oligomerization could help safeguard photoreceptor function under intense illumination. In bright light, ROS disks are saturated and cease functioning as photoreceptors, yet must remain viable until ambient light levels fall. One protective mechanism could involve the clustering of bleached rhodopsins, which would facilitate efficient arrestin binding despite substoichiometric arrestin expression. As reported before [41–43], arrestin binding to rhodopsin oligomers could effectively quench excess signaling, thereby safeguarding ROS disks integrity during periods of intense illumination.
We should also point out that the current experimental methodology has certain limitations. The reconstitution procedure used produces rhodopsin with roughly equal amounts of N-, and C-termini of rhodopsin on the surface of liposomes. Therefore, we are not able to exclude that opsin oligomers are not vectorially oriented, a condition that is non-physiological. Furthermore, even after contrast matching, signal intensity at Q < 0.01 Å−1 was dominated by scattering from the perdeuterated lipid matrix. Although the SANS profile is well-fit in the case of protein-free liposomes, we were never able to completely contrast-match the lipid matrix of proteoliposomes samples (Fig. SI1B, C). Overall, however, the ability of SANS to monitor changes in the oligomeric states of GPCRs within a membrane environment, under different functional conditions, highlights SANS’s sensitivity and utility to changes in protein-protein interactions within the lipid bilayer.
5. Conclusion
Our SANS study successfully implemented neutron contrast strategies to elucidate the oligomeric state of the prototypical GPCR, rhodopsin, in a relevant lipid vesicle environment and when complexed with its cognate G-protein transducin. Our data clearly show the protein transitioning to a multimeric state upon photoactivation and decaying to opsin, highlighting the dynamic nature of GPCR self-association and the ability of SANS to track these changes within the membrane. The efficacy of SANS in lipid vesicles provides a valuable tool for future investigations of membrane protein organization and interactions under physiologically relevant conditions. The procedures for conducting SANS experiments on integral membrane-incorporated proteins are applicable to the study of other membrane proteins. Although early experiments suffered from a lack of availability of perdeuterated lipids, this is less so today. We hope to make even better use of SANS to study protein oligomerization in the future, based on the current results, which underscore the complex interplay between GPCRs, their partners, and the lipid environment needed for initiating cellular signaling.
Supplementary Material
Highlights.
Small Angle Neutron Scattering showed that dark-adapted rhodopsin is monomeric at low protein-membrane concentrations.
Opsin forms higher order oligomers in membranes.
Photoactivation of rhodopsin with its G protein results in a 1:1 complex, consistent with recent cryo-EM data.
SANS with contrast matching in lipid vesicles reveals GPCR oligomerization in biologically relevant membranes.
Acknowledgements
This work is dedicated to Joachim Seelig, whose groundbreaking research on the structure and thermodynamics of biological membranes and pioneering advancements in electron spin resonance and nuclear magnetic resonance spectroscopy provided crucial insights into protein-lipid interactions and membrane structure.
Prof. Alan Grossfield is thanked for gracefully sharing all-atom molecular dynamics simulations of rhodopsin.
Funding
The research was supported by the Intramural Research Program of the National Institute of Alcoholism and Alcohol Abuse (Project 1ZIAAA000003-28 supported O.S, K.G.H, W.E.T, J.K.N and K.G) and of the National Cancer Institute (Project BC007365 supported O.S ). J.K. is supported through the Scientific User Facilities Division of the Department of Energy (DOE) Office of Science, sponsored by the Basic Energy Science (BES) Program, DOE Office of Science, under Contract No. DE-AC05-00OR22725. J.D.N is supported by the National Science Foundation under grant no. 2146264.
Footnotes
CRediT authorship contribution statement
Olivier Soubias: Writing – review & editing, Writing – original draft, Data acquisition and analysis, Conceptualization. Jonathan D. Nickels: Writing – review & editing, Writing – original draft, Data acquisition and analysis, Conceptualization. Kirk G. Hines: Data curation. Walter E. Teague Data curation. John K. Northup: Writing – review & editing, Conceptualization. John Katsaras: Writing – review & editing, Writing – original draft, Conceptualization. Klaus Gawrisch: Writing – original draft, Data acquisition and analysis, Conceptualization, Funding.
Declaration of competing interest
The authors declare no conflict of interest.
Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.
References
- [1].Kogut-Gunthel MM, Zara Z, Nicoli A, Steuer A, Lopez-Balastegui M, Selent J, Karanth S, Koehler M, Ciancetta A, Abiko LA, Hagn F, Di Pizio A, The path to the G protein-coupled receptor structural landscape: Major milestones and future directions, Br J Pharmacol, (2024). [DOI] [PubMed] [Google Scholar]
- [2].Liu X, Xu X, Hilger D, Aschauer P, Tiemann JKS, Du Y, Liu H, Hirata K, Sun X, Guixa-Gonzalez R, Mathiesen JM, Hildebrand PW, Kobilka BK, Structural Insights into the Process of GPCR-G Protein Complex Formation, Cell, 177 (2019) 1243–1251 e1212. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [3].Hilger D, Masureel M, Kobilka BK, Structure and dynamics of GPCR signaling complexes, Nat Struct Mol Biol, 25 (2018) 4–12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [4].Gulati S, Palczewski K, Structural view of G protein-coupled receptor signaling in the retinal rod outer segment, Trends Biochem Sci, 48 (2023) 172–186. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [5].Litman BJ, Purification of rhodopsin by concanavalin A affinity chromatography, Methods Enzymol, 81 (1982) 150–153. [DOI] [PubMed] [Google Scholar]
- [6].Fawzi AB, Fay DS, Murphy EA, Tamir H, Erdos JJ, Northup JK, Rhodopsin and the retinal G-protein distinguish among G-protein beta gamma subunit forms, J Biol Chem, 266 (1991) 12194–12200. [PubMed] [Google Scholar]
- [7].Dartnall HJ, Photosensitivities of Visual Pigments in Presence of Hydroxylamine, Vision Res, 8 (1968) 339-+. [DOI] [PubMed] [Google Scholar]
- [8].Kim JE, Tauber MJ, Mathies RA, Analysis of the mode-specific excited-state energy distribution and wavelength-dependent photoreaction quantum yield in rhodopsin, Biophysical Journal, 84 (2003) 2492–2501. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [9].Lynn GW, Heller W, Urban V, Wignall GD, Weiss K, Myles DAA, Bio-SANS - A dedicated facility for neutron structural biology at oak ridge national laboratory, Physica B, 385-86 (2006) 880–882. [Google Scholar]
- [10].Arnold O, Bilheux JC, Borreguero JM, Buts A, Campbell SI, Chapon L, Doucet M, Draper N, Leal RF, Gigg MA, Lynch VE, Markvardsen A, Mikkelson DJ, Mikkelson RL, Miller R, Palmen K, Parker P, Passos G, Perring TG, Peterson PF, Ren S, Reuter MA, Savici AT, Taylor JW, Taylor RJ, Tolchenoy R, Zhou W, Zikoysky J, Mantid-Data analysis and visualization package for neutron scattering and μ SR experiments, Nucl Instrum Meth A, 764 (2014) 156–166. [Google Scholar]
- [11].Hopkins JB, 2: new developments for a free open-source program for small-angle scattering data reduction and analysis, J Appl Crystallogr, 57 (2024) 194–208. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [12].Svergun DI, Richard S, Koch MHJ, Sayers Z, Kuprin S, Zaccai G, Protein hydration in solution: Experimental observation by x-ray and neutron scattering, P Natl Acad Sci USA, 95 (1998) 2267–2272. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [13].Soubias O, Gawrisch K, The role of the lipid matrix for structure and function of the GPCR rhodopsin, Biochim Biophys Acta, 1818 (2012) 234–240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [14].Soubias O, Sodt AJ, Teague WE, Hines KG, Gawrisch K, Physiological changes in bilayer thickness induced by cholesterol control GPCR rhodopsin function, Biophys J, 122 (2023) 973–983. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [15].Soubias O, Teague WE Jr., Hines KG, Gawrisch K, Rhodopsin/lipid hydrophobic matching-rhodopsin oligomerization and function, Biophys J, 108 (2015) 1125–1132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [16].Botelho AV, Huber T, Sakmar TP, Brown MF, Curvature and hydrophobic forces drive oligomerization and modulate activity of rhodopsin in membranes, Biophys J, 91 (2006) 4464–4477. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [17].Grossfield A, Pitman MC, Feller SE, Soubias O, Gawrisch K, Internal hydration increases during activation of the G-protein-coupled receptor rhodopsin, J Mol Biol, 381 (2008) 478–486. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [18].Hargrave PA, Hamm HE, Hofmann KP, Interaction of rhodopsin with the G-protein, transducin, Bioessays, 15 (1993) 43–50. [DOI] [PubMed] [Google Scholar]
- [19].Kuhn H, Early steps in the light-triggered activation of the cyclic GMP enzymatic pathway in rod photoreceptors, Prog Clin Biol Res, 164 (1984) 303–311. [PubMed] [Google Scholar]
- [20].Kuhn H, Chabre M, Light-dependent interactions between rhodopsin and photoreceptor enzymes, Biophys Struct Mech, 9 (1983) 231–234. [DOI] [PubMed] [Google Scholar]
- [21].Gao Y, Hu H, Ramachandran S, Erickson JW, Cerione RA, Skiniotis G, Structures of the Rhodopsin-Transducin Complex: Insights into G-Protein Activation, Mol Cell, 75 (2019) 781–790 e783. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [22].Gao Y, Westfield G, Erickson JW, Cerione RA, Skiniotis G, Ramachandran S, Isolation and structure-function characterization of a signaling-active rhodopsin-G protein complex, J Biol Chem, 292 (2017) 14280–14289. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [23].Kliger DS, Photo-Isomerization Kinetics of Retinal Analogs, Method Enzymol, 88 (1982) 533–542. [Google Scholar]
- [24].Semeraro EF, Marx L, Frewein MPK, Pabst G, Increasing complexity in small-angle X-ray and neutron scattering experiments: from biological membrane mimics to live cells, Soft Matter, 17 (2021) 222–232. [DOI] [PubMed] [Google Scholar]
- [25].Ebel C, Breyton C, Martel A, Examining Membrane Proteins by Neutron Scattering, Biophysics of Membrane Proteins, 2168 (2020) 147–175. [DOI] [PubMed] [Google Scholar]
- [26].Gabel F, Applications of SANS to Study Membrane Protein Systems, Adv Exp Med Biol, 1009 (2017) 201–214. [DOI] [PubMed] [Google Scholar]
- [27].Lycksell M, Rovsnik U, Bergh C, Johansen NT, Martel A, Porcar L, Arleth L, Howard RJ, Lindahl E, Probing solution structure of the pentameric ligand-gated ion channel GLIC by small-angle neutron scattering, Proc Natl Acad Sci U S A, 118 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
- [28].Luchini A, Arleth L, Protocol for Investigating the Interactions Between Intrinsically Disordered Proteins and Membranes by Neutron Reflectometry, Methods Mol Biol, 2141 (2020) 569–584. [DOI] [PubMed] [Google Scholar]
- [29].Larsen AH, Dorosz J, Thorsen TS, Johansen NT, Darwish T, Midtgaard SR, Arleth L, Kastrup JS, Small-angle neutron scattering studies on the AMPA receptor GluA2 in the resting, AMPA-bound and GYKI-53655-bound states, IUCrJ, 5 (2018) 780–793. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [30].Maric S, Skar-Gislinge N, Midtgaard S, Thygesen MB, Schiller J, Frielinghaus H, Moulin M, Haertlein M, Forsyth VT, Pomorski TG, Arleth L, Stealth carriers for low-resolution structure determination of membrane proteins in solution, Acta Crystallogr D Biol Crystallogr, 70 (2014) 317–328. [DOI] [PubMed] [Google Scholar]
- [31].Bayburt TH, Leitz AJ, Xie G, Oprian DD, Sligar SG, Transducin activation by nanoscale lipid bilayers containing one and two rhodopsins, J Biol Chem, 282 (2007) 14875–14881. [DOI] [PubMed] [Google Scholar]
- [32].Bayburt TH, Vishnivetskiy SA, McLean MA, Morizumi T, Huang CC, Tesmer JJ, Ernst OP, Sligar SG, Gurevich VV, Monomeric rhodopsin is sufficient for normal rhodopsin kinase (GRK1) phosphorylation and arrestin-1 binding, J Biol Chem, 286 (2011) 1420–1428. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [33].Ernst OP, Gramse V, Kolbe M, Hofmann KP, Heck M, Monomeric G protein-coupled receptor rhodopsin in solution activates its G protein transducin at the diffusion limit, Proc Natl Acad Sci U S A, 104 (2007) 10859–10864. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [34].Soubias O, Gawrisch K, Probing specific lipid-protein interaction by saturation transfer difference NMR spectroscopy, J Am Chem Soc, 127 (2005) 13110–13111. [DOI] [PubMed] [Google Scholar]
- [35].Soubias O, Teague WE, Gawrisch K, Evidence for specificity in lipid-rhodopsin interactions, J Biol Chem, 281 (2006) 33233–33241. [DOI] [PubMed] [Google Scholar]
- [36].Soubias O, Teague WE Jr., Hines KG, Mitchell DC, Gawrisch K, Contribution of membrane elastic energy to rhodopsin function, Biophys J, 99 (2010) 817–824. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [37].Brown MF, Curvature forces in membrane lipid-protein interactions, Biochemistry, 51 (2012) 9782–9795. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [38].Periole X, Huber T, Marrink SJ, Sakmar TP, G protein-coupled receptors self-assemble in dynamics simulations of model bilayers, J Am Chem Soc, 129 (2007) 10126–10132. [DOI] [PubMed] [Google Scholar]
- [39].Botelho AV, Gibson NJ, Thurmond RL, Wang Y, Brown MF, Conformational energetics of rhodopsin modulated by nonlamellar-forming lipids, Biochemistry, 41 (2002) 6354–6368. [DOI] [PubMed] [Google Scholar]
- [40].Soubias O, Teague WE, Hines KG, Gawrisch K, The role of membrane curvature elastic stress for function of rhodopsin-like G protein-coupled receptors, Biochimie, 107 Pt A (2014) 28–32. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [41].Sommer ME, Hofmann KP, Heck M, Distinct loops in arrestin differentially regulate ligand binding within the GPCR opsin, Nat Commun, 3 (2012) 995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [42].Sommer ME, Hofmann KP, Heck M, Not just signal shutoff: the protective role of arrestin-1 in rod cells, Handb Exp Pharmacol, 219 (2014) 101–116. [DOI] [PubMed] [Google Scholar]
- [43].Song X, Vishnivetskiy SA, Gross OP, Emelianoff K, Mendez A, Chen J, Gurevich EV, Burns ME, Gurevich VV, Enhanced arrestin facilitates recovery and protects rods lacking rhodopsin phosphorylation, Curr Biol, 19 (2009) 700–705. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.




